The Identification of Torsades de Pointes via CEEG: A Case Report on a Patient with Physiologically Provoked Nonepileptic Events

REFERENCES

• Danielsson B, Collin J, Bergman GJ, Borg N, Salmi P, Fastbom J. 2015. Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults—a Swedish nationwide study. Br J Clin Pharmacol. 81(4):773–783. doi:10.1111/bcp.12829.
   Web of Science ®Google Scholar
• Dessertenne F. 1966. La tachycardie ventriculaire a deux foyers opposés variables. Arch Mal Coeur Vaiss. 59:263–272.
   PubMedGoogle Scholar
• Drew B, Ackerman M, Funk M, Bigler W, Kligfield P, Menon V, Philippides G, Roden D, Zareba W. 2010. Prevention of Torsade de pointes in hospital settings. A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 121:1047–1060. doi:10.1161/CIRCULATIONAHA.109.192704.
   PubMed Web of Science ®Google Scholar
• Faught E. 1993. Current role of electroencephalography in cerebral ischemia. Stroke. 24(4):609–613. doi:10.1161/01.STR.24.4.609.
   PubMed Web of Science ®Google Scholar
• Fayssoil A, Issi J, Guerbaa M, Raynaud JC, Heroguelle V. 2011. Torsade de pointes induced by citalopram and amiodarone. Annales de Cardiologie et d’Angéiologie. 60(3):165–168. doi:10.1016/j.ancard.2010.12.002
   PubMedGoogle Scholar
• Gucyetmez B, Atalan HK, Aslan S, Berktas M, Yazar S, Erturer A, Sozenoglu, IR, Denizalti TB, Polat KY. 2015. Effects of intraoperative magnesium sulfate administration on postoperative tramadol requirement in liver transplant patients. Intensive Care Medicine Experimental. 3(Suppl 1):A694. doi:10.1186/2197-425X-3-S1-A694.
   Google Scholar
• Hockaday J, Potts F, Epstein E, Bonazzi A, Schwab R. 1965. Electroencephalographic changes in acute cerebral anoxia from cardiac or respiratory arrest. Electroenceph Clin Neurophysiol. 18:575–586. doi:10.1016/0013-4694(65)90075-1.
   PubMedGoogle Scholar
• Hohnloser S, Klingenheben T, Singh BN. 1994. Amiodarone-associated proarrhythmic effects—A review with special reference to torsade de pointes tachycardia. Ann Intern Med. 121:529–535. doi:10.7326/0003-4819-121-7-199410010-00009.
   PubMed Web of Science ®Google Scholar
• Ibrahim M, Omar B. 2012. Ciprofloxacin-induced torsade de pointes. Am J Emerg Med. 30(1):252.e5–e9. doi:10.1016/j.ajem.2010.09.039.
   Web of Science ®Google Scholar
• LaFrance Jr WC, Baker GA, Duncan R, Goldstein LH, Reuber M. 2013. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach. A report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia. 54( 11):2005–2018. doi:10.1111/epi.12356.
   Google Scholar
• Martin R, Burneo JG, Prasad A, Powell T, Faught E, Knowlton R, Mendez M, Kuzniecky R. 2003. Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG. Neurology. 61(12):1791–1792. doi:10.1212/01.WNL.0000098890.13946.F5.
   PubMed Web of Science ®Google Scholar
• Moss A, Schwartz P, Crampton R, Tzivoni D, Locati E, MacCluer J, Hall W, Weitkamp L, Vincent M, Garson A Jr, et al. 1991. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 84:1136–1144. doi:10.1161/01.CIR.84.3.1136.
   PubMed Web of Science ®Google Scholar
• Pana R, Hornby L, Shemie S, Dhanani S, Teitelbaum J. 2016. Time to loss of brain function and activity during circulatory arrest. J Crit Care. 34:77–83. doi:10.1016/j.jcrc.2016.04.001.
   PubMed Web of Science ®Google Scholar
• Rastegar A. 1990. Serum potassium. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston (MA): Butterworths. Chapter 195. https://www.ncbi.nlm.nih.gov/books/NBK307/ [accessed 2018 April 18].
   Google Scholar
• Tatetsu H, Asou N, Nakamura M, Hanaoka N, Matsuno F, Horikawa K, Mitsuya H. 2006. Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia. Am J Hematol. 81:366–369. doi:10.1002/(ISSN)1096-8652.
   PubMed Web of Science ®Google Scholar
• Trinkley K, Page, II RL, Lien H, Yamanouye K, Tisdale J. 2013. QT Interval prolongation and the risk of torsades de pointes: Essentials for clinicians. Curr Med Res Opin. 29:1719–1726. doi:10.1185/03007995.2013.840568.
   PubMed Web of Science ®Google Scholar
• Trojaborg W, Boysen G. 1973. Relation between EEG, regional cerebral blood flow and internal carotid artery pressure during carotid endarterectomy. Electroencephalogr Clin Neurophysiol. 34:61–69. doi:10.1016/0013-4694(73)90151-X.
   PubMedGoogle Scholar
• Wentlandt M, Morris S, Mitchell S. 2017. Ventricular tachycardia and prolonged QT interval presenting as seizure-like activity. Am J Emerg Med. 35(5):804.e5–e6. doi:10.1016/j.ajem.2016.11.051.
   PubMed Web of Science ®Google Scholar
• Woosley RL, Heise CW, Romero KA. 2018. CredibleMeds. Oro Valley (AZ): AZCERT, Inc. [accessed 2018 Jan 16]. https://crediblemeds.org/index.php/login/dlcheck.
   Google Scholar
• Yap YG, Camm AJ. 2003. Drug induced QT prolongation and torsades de pointes. Heart. 89(11):1363–1372. doi:10.1136/heart.89.11.1363.
   PubMed Web of Science ®Google Scholar
• Zareba W, Moss A, Schwartz P, Vincent G, Robinson J, Priori S, Benhorin J, Locati E, Towbin J, Keating M, et al. 1998. Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 339(14):960–965. doi:10.1056/NEJM199810013391404.
   PubMed Web of Science ®Google Scholar
• Zeltser D, Justo D, Halkin A, Prokhorov V, Heller K, Viskin S. 2003. Torsade de pointes due to noncardiac drugs—most patients have easily identifiable risk factors. Medicine. 82(4):282–290. doi:10.1097/01.md.0000085057.63483.9b.
   PubMed Web of Science ®Google Scholar
• Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, et al. 2006. American College of Cardiology/American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association and the Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death–executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 27(17):2099–2140.
   PubMed Web of Science ®Google Scholar